These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 2565808

  • 1. HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor.
    Lee J, Dull TJ, Lax I, Schlessinger J, Ullrich A.
    EMBO J; 1989 Jan; 8(1):167-73. PubMed ID: 2565808
    [Abstract] [Full Text] [Related]

  • 2. A chimeric EGF-R-neu proto-oncogene allows EGF to regulate neu tyrosine kinase and cell transformation.
    Lehväslaiho H, Lehtola L, Sistonen L, Alitalo K.
    EMBO J; 1989 Jan; 8(1):159-66. PubMed ID: 2565807
    [Abstract] [Full Text] [Related]

  • 3. A chimeric EGFR/neu receptor in studies of neu function.
    Lehtola L, Lehväslaiho H, Koskinen P, Alitalo K.
    Cancer Treat Res; 1992 Jan; 61():213-28. PubMed ID: 1360234
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. An oncogenic point mutation confers high affinity ligand binding to the neu receptor. Implications for the generation of site heterogeneity.
    Ben-Levy R, Peles E, Goldman-Michael R, Yarden Y.
    J Biol Chem; 1992 Aug 25; 267(24):17304-13. PubMed ID: 1355090
    [Abstract] [Full Text] [Related]

  • 7. A chimeric EGFR/neu receptor in functional analysis of the neu oncoprotein.
    Lehtola L, Lehväslaiho H, Koskinen P, Alitalo K.
    Acta Oncol; 1992 Aug 25; 31(2):147-50. PubMed ID: 1352454
    [Abstract] [Full Text] [Related]

  • 8. Oncogenic forms of the neu/HER2 tyrosine kinase are permanently coupled to phospholipase C gamma.
    Peles E, Levy RB, Or E, Ullrich A, Yarden Y.
    EMBO J; 1991 Aug 25; 10(8):2077-86. PubMed ID: 1676673
    [Abstract] [Full Text] [Related]

  • 9. Biological and biochemical activities of a chimeric epidermal growth factor-Elk receptor tyrosine kinase.
    Lhoták V, Pawson T.
    Mol Cell Biol; 1993 Nov 25; 13(11):7071-9. PubMed ID: 8413296
    [Abstract] [Full Text] [Related]

  • 10. A ligand-inducible epidermal growth factor receptor/anaplastic lymphoma kinase chimera promotes mitogenesis and transforming properties in 3T3 cells.
    Piccinini G, Bacchiocchi R, Serresi M, Vivani C, Rossetti S, Gennaretti C, Carbonari D, Fazioli F.
    J Biol Chem; 2002 Jun 21; 277(25):22231-9. PubMed ID: 11919185
    [Abstract] [Full Text] [Related]

  • 11. Epidermal growth factor (EGF) modulation of feline sarcoma virus fms tyrosine kinase activity, internalization, degradation, and transforming potential in an EGF receptor/v-fms chimera.
    Riedel H.
    J Virol; 1994 Jan 21; 68(1):411-24. PubMed ID: 8254751
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain.
    Cohen BD, Goldstein DJ, Rutledge L, Vass WC, Lowy DR, Schlegel R, Schiller JT.
    J Virol; 1993 Sep 21; 67(9):5303-11. PubMed ID: 8394451
    [Abstract] [Full Text] [Related]

  • 14. A chimeric, ligand-binding v-erbB/EGF receptor retains transforming potential.
    Riedel H, Schlessinger J, Ullrich A.
    Science; 1987 Apr 10; 236(4798):197-200. PubMed ID: 3494307
    [Abstract] [Full Text] [Related]

  • 15. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
    Kokai Y, Dobashi K, Weiner DB, Myers JN, Nowell PC, Greene MI.
    Proc Natl Acad Sci U S A; 1988 Aug 10; 85(15):5389-93. PubMed ID: 2899889
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Heterodimerization of c-erbB2 with different epidermal growth factor receptor mutants elicits stimulatory or inhibitory responses.
    Spivak-Kroizman T, Rotin D, Pinchasi D, Ullrich A, Schlessinger J, Lax I.
    J Biol Chem; 1992 Apr 25; 267(12):8056-63. PubMed ID: 1349015
    [Abstract] [Full Text] [Related]

  • 18. Differential heat stress stability of epidermal growth factor receptor and erbB-2 receptor tyrosine kinase activities.
    Liu SM, Carpenter G.
    J Cell Physiol; 1993 Nov 25; 157(2):237-42. PubMed ID: 7901224
    [Abstract] [Full Text] [Related]

  • 19. Regulation by EGF is maintained in an overexpressed chimeric EGFR/neu receptor tyrosine kinase.
    Lehväslaiho H, Sistonen L, diRenzo F, Partanen J, Comoglio P, Hölttä E, Alitalo K.
    J Cell Biochem; 1990 Mar 25; 42(3):123-33. PubMed ID: 1969420
    [Abstract] [Full Text] [Related]

  • 20. Constitutive association of EGF receptor with the CrkII-23 mutant that inhibits transformation of NRK cells by EGF and TGF-beta.
    Ota S, Kizaka-Kondoh S, Hashimoto Y, Nishihara H, Nagashima K, Kurata T, Okayama H, Matsuda M.
    Cell Signal; 1998 Apr 25; 10(4):283-90. PubMed ID: 9617486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.